KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 159 filers reported holding KITE PHARMA INC in Q2 2015. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,585,000 | -20.0% | 146,855 | -0.3% | 0.01% | -20.0% |
| Q3 2016 | $8,229,000 | +12.6% | 147,320 | +0.7% | 0.01% | +11.1% |
| Q2 2016 | $7,311,000 | +41.9% | 146,226 | +30.3% | 0.01% | +28.6% |
| Q1 2016 | $5,153,000 | -13.6% | 112,234 | +16.0% | 0.01% | -12.5% |
| Q4 2015 | $5,961,000 | +11.4% | 96,738 | +0.6% | 0.01% | +14.3% |
| Q3 2015 | $5,352,000 | -10.1% | 96,118 | -1.6% | 0.01% | 0.0% |
| Q2 2015 | $5,953,000 | +291.9% | 97,633 | +270.6% | 0.01% | +250.0% |
| Q1 2015 | $1,519,000 | -11.0% | 26,343 | -10.9% | 0.00% | 0.0% |
| Q4 2014 | $1,706,000 | +156.2% | 29,574 | +26.6% | 0.00% | +100.0% |
| Q3 2014 | $666,000 | – | 23,365 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |